Helsen Pharma & Consulting

Geel ·KBO/BCE: BE 0799.409.266

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	9.2%	38.7%	better than 22% of 768 sector peers
Net result	€14k	€28k	better than 37% of 767 sector peers
Equity	€24k	€63k	better than 31% of 768 sector peers
Gross operating margin	€35k	€67k	better than 31% of 765 sector peers
Total assets	€262k	€190k	better than 57% of 768 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€262k
Fixed assets	21/28	€252k
Financial fixed assets	28	€252k
Current assets	29/58	€10k
Cash & bank	54/58	€9k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€262k
Equity	10/15	€24k
Contributions / capital	10/11	€10k
Reserves	13	€14k
Amounts payable	17/49	€238k
Amounts payable after one year	17	€152k
Amounts payable within one year	42/48	€84k
Trade debts payable within one year	44	€1k
Income statement
Gross operating margin	9900	€35k
Operating result	9901	€34k
Financial charges	65	€15k
Result before taxes	9903	€19k
Income taxes	67/77	€5k
Net result for the period	9904	€14k
Result to be appropriated	9905	€14k

Legal nameNL	Helsen Pharma & Consulting
AbbreviationNL	H P C

Summary